Later trials will have to be done with new participants. Patients in this trial may be able to continue treatment if they are getting positive effect - that would be sponsor company decision made with input from contracted research team and be included as clause in DF's informed consent. I don't know if Cellcuetix included that in their informed consent or not. That differs company by company.